Wordt geladen...
2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks
Osteosarcoma is the most common malignant bone tumor in children and young adults, and it has a survival rate of only 60% with current cytotoxic chemotherapy combined with aggressive surgery. The aim of this study was to evaluate the therapeutic efficacy of the berbamine derivative 2-methylbenzoyl b...
Bewaard in:
| Gepubliceerd in: | Aging (Albany NY) |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425514/ https://ncbi.nlm.nih.gov/pubmed/32713851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103565 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|